LUMAKRAS® (SOTORASIB) CODEBREAK 100 STUDY SHOWS TWO-YEAR OVERALL SURVIVAL OF 32.5% IN PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER – QNT Press Release5 years ago
FINAL DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action – AFIB – QNT Press Release5 years ago
Prominent Russian activist detained after Moscow anti-war protest | Russia-Ukraine war News5 years ago
Questex’s International Esthetics, Cosmetics & Spa Conference (IECSC) Chicago Returns to the Donald E. Stephens Convention Center, April 10-11 – QNT Press Release5 years ago
